Tectonic Therapeutic (TECX) Competitors $44.03 +3.17 (+7.76%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends TECX vs. JANX, CPRX, IOVA, TWST, LBPH, ARWR, PTGX, IDYA, NAMS, and CGONShould you be buying Tectonic Therapeutic stock or one of its competitors? The main competitors of Tectonic Therapeutic include Janux Therapeutics (JANX), Catalyst Pharmaceuticals (CPRX), Iovance Biotherapeutics (IOVA), Twist Bioscience (TWST), Longboard Pharmaceuticals (LBPH), Arrowhead Pharmaceuticals (ARWR), Protagonist Therapeutics (PTGX), IDEAYA Biosciences (IDYA), NewAmsterdam Pharma (NAMS), and CG Oncology (CGON). These companies are all part of the "pharmaceutical products" industry. Tectonic Therapeutic vs. Janux Therapeutics Catalyst Pharmaceuticals Iovance Biotherapeutics Twist Bioscience Longboard Pharmaceuticals Arrowhead Pharmaceuticals Protagonist Therapeutics IDEAYA Biosciences NewAmsterdam Pharma CG Oncology Janux Therapeutics (NASDAQ:JANX) and Tectonic Therapeutic (NASDAQ:TECX) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, community ranking, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk. Is JANX or TECX more profitable? Tectonic Therapeutic has a net margin of 0.00% compared to Janux Therapeutics' net margin of -463.91%. Janux Therapeutics' return on equity of -10.47% beat Tectonic Therapeutic's return on equity.Company Net Margins Return on Equity Return on Assets Janux Therapeutics-463.91% -10.47% -9.86% Tectonic Therapeutic N/A -35.53%-31.97% Do analysts rate JANX or TECX? Janux Therapeutics presently has a consensus price target of $66.44, indicating a potential upside of 35.71%. Tectonic Therapeutic has a consensus price target of $72.25, indicating a potential upside of 64.09%. Given Tectonic Therapeutic's stronger consensus rating and higher possible upside, analysts plainly believe Tectonic Therapeutic is more favorable than Janux Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Janux Therapeutics 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.90Tectonic Therapeutic 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17 Do insiders & institutionals believe in JANX or TECX? 75.4% of Janux Therapeutics shares are owned by institutional investors. Comparatively, 62.6% of Tectonic Therapeutic shares are owned by institutional investors. 29.4% of Janux Therapeutics shares are owned by insiders. Comparatively, 9.2% of Tectonic Therapeutic shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more risk & volatility, JANX or TECX? Janux Therapeutics has a beta of 3.52, suggesting that its share price is 252% more volatile than the S&P 500. Comparatively, Tectonic Therapeutic has a beta of 2.6, suggesting that its share price is 160% more volatile than the S&P 500. Does the media refer more to JANX or TECX? In the previous week, Janux Therapeutics and Janux Therapeutics both had 3 articles in the media. Tectonic Therapeutic's average media sentiment score of 0.62 beat Janux Therapeutics' score of -0.02 indicating that Tectonic Therapeutic is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Janux Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Tectonic Therapeutic 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better valuation & earnings, JANX or TECX? Tectonic Therapeutic has lower revenue, but higher earnings than Janux Therapeutics. Janux Therapeutics is trading at a lower price-to-earnings ratio than Tectonic Therapeutic, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJanux Therapeutics$8.08M318.00-$58.29M-$1.17-41.85Tectonic TherapeuticN/AN/A$12.16M-$5.89-7.48 Does the MarketBeat Community believe in JANX or TECX? Janux Therapeutics received 25 more outperform votes than Tectonic Therapeutic when rated by MarketBeat users. However, 100.00% of users gave Tectonic Therapeutic an outperform vote while only 66.67% of users gave Janux Therapeutics an outperform vote. CompanyUnderperformOutperformJanux TherapeuticsOutperform Votes3266.67% Underperform Votes1633.33% Tectonic TherapeuticOutperform Votes7100.00% Underperform VotesNo Votes SummaryJanux Therapeutics beats Tectonic Therapeutic on 9 of the 17 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Tectonic Therapeutic News Delivered to You Automatically Sign up to receive the latest news and ratings for TECX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TECX vs. The Competition Export to ExcelMetricTectonic TherapeuticBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$649.58M$2.95B$5.06B$8.89BDividend YieldN/A1.90%4.97%4.06%P/E Ratio-7.4817.8689.0213.30Price / SalesN/A222.321,207.2881.01Price / CashN/A160.0839.1736.03Price / Book20.674.906.085.74Net Income$12.16M-$41.63M$119.07M$225.93M7 Day Performance1.78%-4.73%-1.84%-1.32%1 Month Performance19.32%-6.53%-3.65%0.60%1 Year PerformanceN/A25.63%31.62%26.23% Tectonic Therapeutic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TECXTectonic Therapeutic3.5107 of 5 stars$44.03+7.8%$72.25+64.1%N/A$649.58MN/A-7.48120Analyst ForecastGap UpHigh Trading VolumeJANXJanux Therapeutics3.5908 of 5 stars$48.96-0.1%$66.44+35.7%+441.0%$2.57B$8.08M0.0030CPRXCatalyst Pharmaceuticals4.7417 of 5 stars$21.15-1.1%$31.14+47.2%+54.3%$2.55B$398.20M17.92167Analyst ForecastIOVAIovance Biotherapeutics4.0475 of 5 stars$8.14-0.6%$22.33+174.4%+48.3%$2.50B$1.19M0.00500Options VolumeTWSTTwist Bioscience4.1398 of 5 stars$41.11-0.5%$51.78+25.9%+66.2%$2.45B$312.97M0.00990Analyst ForecastAnalyst RevisionLBPHLongboard Pharmaceuticals1.4685 of 5 stars$59.77-0.1%$59.56-0.4%+1,283.6%$2.34BN/A0.0020ARWRArrowhead Pharmaceuticals3.5698 of 5 stars$18.71+0.6%$45.33+142.3%-35.3%$2.31B$240.74M0.00400Upcoming EarningsAnalyst ForecastPTGXProtagonist Therapeutics3.0192 of 5 stars$40.65+5.2%$53.57+31.8%+135.8%$2.30B$60M15.28125Analyst ForecastNews CoverageIDYAIDEAYA Biosciences4.1381 of 5 stars$25.54-1.2%$53.67+110.1%-17.1%$2.24B$23.39M0.0080Analyst ForecastNAMSNewAmsterdam Pharma2.936 of 5 stars$20.01-15.5%$33.80+68.9%+110.6%$2.19B$14.09M0.0057Insider TradeNews CoverageGap DownHigh Trading VolumeCGONCG Oncology3.1626 of 5 stars$32.24-1.7%$63.88+98.1%N/A$2.18B$684,000.000.0061Short Interest ↓Analyst Revision Related Companies and Tools Related Companies Janux Therapeutics Competitors Catalyst Pharmaceuticals Competitors Iovance Biotherapeutics Competitors Twist Bioscience Competitors Longboard Pharmaceuticals Competitors Arrowhead Pharmaceuticals Competitors Protagonist Therapeutics Competitors IDEAYA Biosciences Competitors NewAmsterdam Pharma Competitors CG Oncology Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TECX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tectonic Therapeutic Please log in to your account or sign up in order to add this asset to your watchlist. Share Tectonic Therapeutic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TECX Stock Alerts